Avenue Therapeutics ATXI
OTC ATXI
$0.40 -0.03 (-6.98%)
At close: Oct 20, 2026 · 4:00 PM EDT

Avenue Therapeutics (ATXI) Debt Ratio (2016 - 2017)

Updated

Avenue Therapeutics' (ATXI) Debt Ratio came in at 0.11 for Q2 2017, down 99.4% from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Debt Ratio (2016 - 2017) Analysis & Trends

For FY2016, Avenue Therapeutics' Debt Ratio stood at 23.73.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 0.11
Mar 31, 2017 17.21
Dec 31, 2016 38.07
API Access

Avenue Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ATXI&period=max&api_key=YOUR_API_KEY